Shopping Cart
- Remove All
- Your shopping cart is currently empty
CGS 15943 is an orally bioavailable non-xanthine antagonist of the Adenosine Receptor. In transfected CHO cells, its Ki values for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 37 € | In Stock | |
5 mg | 86 € | In Stock | |
10 mg | 126 € | In Stock | |
25 mg | 211 € | In Stock | |
50 mg | 316 € | In Stock | |
100 mg | 473 € | In Stock | |
1 mL x 10 mM (in DMSO) | 88 € | In Stock |
Description | CGS 15943 is an orally bioavailable non-xanthine antagonist of the Adenosine Receptor. In transfected CHO cells, its Ki values for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM, respectively. |
Targets&IC50 | A2B receptor:16 nM (ki), p110δ:8.47 μM, A3 receptor:51 nM (ki), A2A receptor:4.2 nM (ki), p110γ:1.1 μM, A1 receptor:3.5 nM (ki) |
In vitro | CGS 15943 inhibits the kinase activity of the class IB PI3K isoform p110γ (IC50: 1.1 μM). CGS 15943 shows slight inhibition on p110δ (IC50: 8.47 μM). CGS 15943 (0-20 μM; 24 hours) reduces the phosphorylation of Akt at its residues Ser473 and Thr308 in HLF and Sk-Hep-1 cells. CGS 15943 (0-20 μM; 72 hours) inhibits growth of HLF and SK-Hep-1 cells, as well as HepG2 and PLC-PRF-5 cells[3]. |
Molecular Weight | 285.69 |
Formula | C13H8ClN5O |
Cas No. | 104615-18-1 |
Smiles | Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1 |
Relative Density. | 1.72 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 12.22 mg/mL (42.77 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.